Session Information
2011 Summer Meeting
Click here to go to the previous page
Validating Sterile Compounding of IV Robotic Technology Using USP 797 Quality Assurance Programs
Track:
Education Sessions (CE)
Program Code: 103-L03
Date: Sunday, June 12, 2011
Time: 2:00 PM to 4:00 PM MST
Location:
203
PRESENTER(S):
Marc Holley
Mr. Eric Kastango, MBA, RPh, President/CEO, Clinical IQ, LLC
Dennis Tribble
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Description
Keep up with IV robotic technology: learn which USP <797> quality assurance standards apply in your situation and prepare yourself to implement those standards with two different IV robotic technologies. Along the way, you’ll become conversant on the advantages and disadvantages of human vs. robotic sterile compounding.
- Compare the use of IV robots to compound sterile preparations to manual (human) compounding.
- Explain the motivation to develop requirements for pharmacy-based sterile compounding.
- List the primary QA components required by USP 797 for environment, primary engineering controls, and compounding personnel.
This session is a part of:
This session is a part of: